BR0112141A - Peptìdeos, polipeptìdeo, composição, uso de um peptìdeo ou um polipeptìdeo, e, anticorpo - Google Patents
Peptìdeos, polipeptìdeo, composição, uso de um peptìdeo ou um polipeptìdeo, e, anticorpoInfo
- Publication number
- BR0112141A BR0112141A BR0112141-3A BR0112141A BR0112141A BR 0112141 A BR0112141 A BR 0112141A BR 0112141 A BR0112141 A BR 0112141A BR 0112141 A BR0112141 A BR 0112141A
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptides
- polypeptide
- peptide
- pertactin
- antibody
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 13
- 229920001184 polypeptide Polymers 0.000 title abstract 10
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 10
- 239000000203 mixture Substances 0.000 title abstract 3
- 108010021711 pertactin Proteins 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 201000005702 Pertussis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
"PEPTìDEO, POLIPEPTìDEO, COMPOSIçãO, USO DE UM PEPTìDEO OU UM POLIPEPTìDEO, E, ANTICORPO". A presente invenção apresenta polipeptídeos para uso em vacinas contra a coqueluche e a paracoqueluche. Os polipeptídeos da invenção são derivados da pertactina de Bordetella pertussis. Preferivelmente, os polipeptídeos da invenção compreendem seq³ências da região 1 de pertactina, em particular eles compreendem uma ou mais repetições "GGFGP" ou "GGAVP". Alternativamente, os polipeptídeos da invenção têm uma seq³ência de pertactina, da qual parte, ou toda, da região 1, ou da região 2, é deletada. Os polipeptídeos da invenção são incorporados em composições que são úteis como vacinas para seres humanos e fins veterinários. A invenção ainda apresenta anticorpos contra os polipeptídeos da invenção derivados de pertactina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00202309A EP1174505A1 (en) | 2000-06-30 | 2000-06-30 | (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides |
PCT/NL2001/000493 WO2002000695A2 (en) | 2000-06-30 | 2001-06-29 | Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0112141A true BR0112141A (pt) | 2003-05-06 |
Family
ID=8171731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0112141-3A BR0112141A (pt) | 2000-06-30 | 2001-06-29 | Peptìdeos, polipeptìdeo, composição, uso de um peptìdeo ou um polipeptìdeo, e, anticorpo |
Country Status (10)
Country | Link |
---|---|
US (1) | US20030187221A1 (pt) |
EP (2) | EP1174505A1 (pt) |
JP (1) | JP2004501933A (pt) |
KR (1) | KR20030032976A (pt) |
AU (2) | AU2001271124B2 (pt) |
BR (1) | BR0112141A (pt) |
CA (1) | CA2415238A1 (pt) |
MX (1) | MXPA02012664A (pt) |
NZ (1) | NZ523354A (pt) |
WO (1) | WO2002000695A2 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3928274A1 (de) * | 1989-08-26 | 1991-02-28 | Weissheimer Friedr Malzfab | Verfahren zur herstellung eines malzproduktes fuer lebensmittel, insbesondere fuer die bierherstellung und nach diesem verfahren hergestelltes malzprodukt |
CU23679A1 (es) | 2007-10-30 | 2011-07-11 | Ct Ingenieria Genetica Biotech | Variantes de pertactinas para uso vacunal |
ES2597832T3 (es) * | 2013-03-08 | 2017-01-23 | Janssen Vaccines & Prevention B.V. | Vacuna acelular contra la tosferina |
KR102426041B1 (ko) * | 2017-08-01 | 2022-07-29 | 주식회사 녹십자 | 냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9007416D0 (en) * | 1990-04-02 | 1990-05-30 | Wellcome Found | Expression of heterologous protein in yeast |
US6287857B1 (en) * | 1998-02-09 | 2001-09-11 | Genzyme Corporation | Nucleic acid delivery vehicles |
-
2000
- 2000-06-30 EP EP00202309A patent/EP1174505A1/en not_active Withdrawn
-
2001
- 2001-06-29 BR BR0112141-3A patent/BR0112141A/pt not_active IP Right Cessation
- 2001-06-29 US US10/312,732 patent/US20030187221A1/en not_active Abandoned
- 2001-06-29 NZ NZ523354A patent/NZ523354A/en unknown
- 2001-06-29 MX MXPA02012664A patent/MXPA02012664A/es unknown
- 2001-06-29 AU AU2001271124A patent/AU2001271124B2/en not_active Ceased
- 2001-06-29 JP JP2002505817A patent/JP2004501933A/ja active Pending
- 2001-06-29 EP EP01950093A patent/EP1294890A2/en not_active Withdrawn
- 2001-06-29 CA CA002415238A patent/CA2415238A1/en not_active Abandoned
- 2001-06-29 KR KR1020027018002A patent/KR20030032976A/ko not_active Application Discontinuation
- 2001-06-29 WO PCT/NL2001/000493 patent/WO2002000695A2/en not_active Application Discontinuation
- 2001-06-29 AU AU7112401A patent/AU7112401A/xx active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004501933A (ja) | 2004-01-22 |
MXPA02012664A (es) | 2004-05-14 |
EP1294890A2 (en) | 2003-03-26 |
AU2001271124B2 (en) | 2006-11-23 |
AU7112401A (en) | 2002-01-08 |
US20030187221A1 (en) | 2003-10-02 |
KR20030032976A (ko) | 2003-04-26 |
WO2002000695A2 (en) | 2002-01-03 |
WO2002000695A3 (en) | 2002-08-08 |
EP1174505A1 (en) | 2002-01-23 |
CA2415238A1 (en) | 2002-01-03 |
NZ523354A (en) | 2005-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
PT1090033E (pt) | Particulas de proteinas de envelope do hcv: utilizacao para vacinacao | |
AR006999A1 (es) | Una composición inmunogénica, terapéutica o profiláctica , que comprende un polipéptido omp106 aislado, un anticuerpo aislado que se liga a dicho polipéptido y una vacuna que lo comprende. | |
BG102714A (en) | Pharmaceutical composition for immunomodulation based on peptides and adjuvants | |
BRPI0208183B8 (pt) | peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer | |
BR9306820A (pt) | Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero | |
HK1021824A1 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
GB2439474A (en) | LI-Key/Antigenic epitope hybrid peptide vaccines | |
HUP0104946A2 (hu) | Peptidligandokon keresztül kapcsolódó immunogén összetevőkkel rendelkező HBV-magantigén-részecskék | |
TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
HK1093314A1 (en) | Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens | |
CY1108570T1 (el) | Gd3-μιμητικα πεπτιδια | |
BR0009472A (pt) | Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas | |
ATE287957T1 (de) | Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus | |
ATE205219T1 (de) | Ein verbessertes peptid, immunogene zusammensetzung und impfstoff oder medizinische präparate, eine methode zur immunisierung von tieren gegen das hormon lhrh und analoge des lhrh-tendem-repeat-peptid und deren verwendung als impfstoff | |
BR0112141A (pt) | Peptìdeos, polipeptìdeo, composição, uso de um peptìdeo ou um polipeptìdeo, e, anticorpo | |
SE9604296D0 (sv) | New pharmaceutical formulation of polypeptides | |
LT2002051A (en) | Mimetic peptides for epitope of apoliprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same | |
BR0312273A (pt) | Composição imunogênica, vacina, método para a preparação da mesma, e, uso de uma composição imunogênica | |
BRPI0417286A (pt) | misturas de peptìdeos ou polipeptìdeo antigênicos, peptìdeos antigênicos, polipeptìdeo antigênico, misturas antigênicas, lipopeptìdeo, mixotopo, lipomixotopo, conjugado, composições imunogênicas, vacina contra malária, uso de uma mistura, soro policlonal, anticorpo humano recombinante, usos de uma composição, medicamento, métodos e kits para o diagnóstico in vitro de malária, seqüências de nucleotìdeo, vetor de clonagem e/ou expressão recombinante, uso de um vetor de expressão vacina de dna e célula hospedeira recombinante | |
ATE312923T1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
BR0001717B1 (pt) | Vacina sintética para o controle de carrapatos | |
ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
AP9801399A0 (en) | Zona pellucida proteins for contraception. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009. |